Mesenchymal stem cell and bone marrow mononuclear cell therapy for cardiomyopathy: From bench to bedside-Reference-Cited by-同舟云学术

Mesenchymal stem cell and bone marrow mononuclear cell therapy for cardiomyopathy: From bench to bedside

Published:2018-09-06 Issue:1 Volume:120 Page:45-55
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Dolati Sanam¹²³,Yousefi Mehdi²⁴⁵^ORCID,Mahdipour Mahdi⁴⁶,Afrasiabi Rad Abbas⁷⁸,Pishgahi Alireza⁹,Nouri Mohammad⁴⁶,Jodati Ahmad Reza⁷⁸

Affiliation:

1. Aging Research Institute, Tabriz University of Medical Sciences Tabriz Iran

2. Drug Applied Research Center, Tabriz University of Medical Sciences Tabriz Iran

3. Student’s Research Committee, Tabriz University of Medical Sciences Tabriz Iran

4. Stem Cell Research Center, Tabriz University of Medical Sciences Tabriz Iran

5. Department of Immunology Tabriz University of Medical Sciences Tabriz Iran

6. Department of Reproductive Biology Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences Tabriz Iran

7. Cardiovascular Research Center, Tabriz University of Medical Sciences Tabriz Iran

8. Department of Cardiac Surgery Tabriz University of Medical Tabriz Iran

9. Department of Physical Medicine and Rehabilitation Physical Medicine and Rehabilitation Research Center, Tabriz University of Medical Science Tabriz Iran

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.27531

Reference102 articles.

1. Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease

2. Heart Disease and Stroke Statistics—2014 Update

3. Executive Summary: Heart Disease and Stroke Statistics—2015 Update

4. Cell Therapy for Heart Failure

5. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mesenchymal stem cells ameliorate inflammation and pyroptosis in diabetic cardiomyopathy via the miRNA-223-3p/NLRP3 pathway;Diabetology & Metabolic Syndrome;2024-07-02

2. Application and challenges of stem cells in cardiovascular aging;Regenerative Therapy;2024-03

3. WISP2 downregulation inhibits the osteogenic differentiation of BMSCs in congenital scoliosis by regulating Wnt/β-catenin pathway;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-10

4. Biotecnología aplicada al diagnóstico y tratamiento de la osteoporosis. Avances en biofármacos, bioterapias y biomarcadores. Parte 2;Revista Bioquímica y Patología Clínica;2023-04-25

5. Epigenetic Modification Factors and microRNAs Network Associated with Differentiation of Embryonic Stem Cells and Induced Pluripotent Stem Cells toward Cardiomyocytes: A Review;Life;2023-02-17